This report provides a review of all aspects of influenza vaccine research and development, financing, manufacturing, efficacy, safety, regulatory issues, procurement, distribution, usage, public education, consumer acceptance, and public policy. The authors identify ten key findings and six high-level recommendations that they believe are essential to moving the international influenza vaccine enterprise toward critically needed novel-antigen, game-changing vaccines.

Author(s): Center for Infectious Disease Research & Policy

Published: 2012

Resource types: Report

Diseases: Influenza

Topics: Advocacy and communications; Introduction and service delivery; Vaccine safety; Disease/vaccine specific information

Regions: Global